CASE STUDY

Awareness Campaign for Recurrent Anaplastic Astrocytoma

Awareness Campaign for Recurrent Anaplastic Astrocytoma

A clinical trial was recruiting patients with recurrent Anaplastic Astrocytoma (AA), a grade 3 glioma. The study was being conducted across the US as well as in a number of European countries. AA affects about 5-8 per 100,000 people, and in order to qualify these patients must be experiencing their first recurrence or progression after surgical resection or chemotherapy treatment.

iPhone5_Mockup.jpg

 

 

Related Content